FAIR LAWN, N.J.--(BUSINESS WIRE)--Vyteris, Inc. (OTCBB: VYHN), manufacturer of LidoSite®, the first active transdermal patch approved by the U.S. Food and Drug Administration for the pain associated with blood draws (venipuncture), IV (intravenous) cannulations and laser ablation of superficial skin lesions, today announced the expected assumption by Arthur Courbanou to chair the audit committee on the board of directors after January 1, 2008. Arthur’s appointment to the board was originally announced in a Form 8-K filed on November 13, 2007.
